The historical rank and industry rank for LeMaitre Vascular's Gross Margin % or its related term are showing as below:
LMAT'
s Gross Margin % Range Over the Past 10 Years
Min: 64.89 Med: 68.38 Max: 70.59
Current: 68.63
During the past 13 years, the highestGross Margin % of LeMaitre Vascular was 70.59%. The lowest was 64.89%. And the median was 68.38%.
LMAT's Gross Margin % is ranked better than 75.06% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.915
vs LMAT: 68.63
LeMaitre Vascular had a gross margin of 69.26% for the quarter that ended in Dec. 2024 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for LeMaitre Vascular was 0.10% per year.
LeMaitre Vascular Gross Margin % Historical Data
The historical data trend for LeMaitre Vascular's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of LeMaitre Vascular's Gross Margin %
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular's Gross Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Gross Margin % distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
LeMaitre Vascular had a gross margin of 69.26% for the quarter that ended in Dec. 2024 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
LeMaitre Vascular Gross Margin % Related Terms
Thank you for viewing the detailed overview of LeMaitre Vascular's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LMAT has been successfully added to your 